Telerehabilitation for Cancer

This trial tests a new telerehabilitation program for individuals with lymphoma or myeloma scheduled to receive CAR-T therapy. The program, called Multimodal Telerehabilitation, combines personalized exercise, nutrition plans, and interactive education, all managed online from home. The researchers aim to determine if this approach can improve quality of life and better manage symptoms. Participants must have a confirmed diagnosis of lymphoma or myeloma and plan to receive CAR-T therapy in at least four weeks. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance patient care and quality of life.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that telerehabilitation is generally safe for cancer patients. In a study with 123 cancer survivors, this method proved safe and improved health. Patients adhered well to the program and reported positive experiences. These findings suggest that the treatment is safe for home use, enabling patients to follow personalized exercise and nutrition plans with ongoing support.¹²³⁴⁵

Researchers are excited about the multimodal telerehabilitation approach for cancer patients because it offers a personalized and interactive method for managing and improving health during and after CAR-T therapy. Unlike traditional rehabilitation, which often requires in-person visits, this approach uses an app and web-based portal to provide exercise, nutrition plans, and educational support right at home. By combining technology with behavioral counseling and social support, it empowers patients to actively participate in their recovery, potentially leading to better outcomes and quality of life.

Research shows that telerehabilitation can help cancer patients. Studies have found that cancer survivors using telerehabilitation experience better health and less pain. This method allows patients to exercise at their own pace from home and offers support through interactive technology, enhancing their quality of life. In this trial, participants will undergo a four-week multimodal prehabilitation before CAR-T therapy, followed by a 12-week home-based multimodal telerehabilitation. Early results suggest that patients receiving CAR-T therapy find telerehabilitation easy to use and adhere to. Overall, telerehabilitation is a promising way to aid cancer recovery.¹²⁴⁵⁶